Cargando…
Extracellular vesicles: A promising therapy against SARS-CoV-2 infection
Autores principales: | Leyfman, Yan, Gohring, Greta, Joshi, Muskan, Menon, Gayathri Pramil, Van de Kieft, Alexandra, Rivero, Tania del, Bellio, Michael A., Mitrani, Maria Ines |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155280/ https://www.ncbi.nlm.nih.gov/pubmed/37141856 http://dx.doi.org/10.1016/j.ymthe.2023.03.033 |
Ejemplares similares
-
Human amniotic fluid derived extracellular vesicles attenuate T cell immune response
por: del Rivero, Tania, et al.
Publicado: (2022) -
The Potential of Lifestyle Medicine: Strategies to Optimize Health and Well-Being in Oncology Care with Dr. Amy Comander
por: Chorya, Harshal, et al.
Publicado: (2023) -
The Evolving Landscape: Exploring the Future of Myelodysplastic Syndrome Treatment with Dr. Rami Komrokji
por: Jackewicz, Sean Henry, et al.
Publicado: (2023) -
Cancer and COVID-19: unravelling the immunological interplay with a review of promising therapies against severe SARS-CoV-2 for cancer patients
por: Leyfman, Yan, et al.
Publicado: (2023) -
Administration of amniotic fluid derived extracellular vesicle is associated with decreased crp in COVID-19 patients
por: Mitrani, M., et al.
Publicado: (2021)